The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2015

Filed:

Jun. 24, 2013
Applicant:

Children's Hospital Medical Center, Cincinnati, OH (US);

Inventors:

Ming Tan, Cincinnati, OH (US);

Xi Jiang, Cincinnati, OH (US);

Assignee:

Children's Hospital Medical Center, Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); A61K 38/00 (2006.01); A61K 39/12 (2006.01); A61K 39/125 (2006.01); C07K 5/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 38/00 (2013.01); A61K 39/12 (2013.01); A61K 39/125 (2013.01); C07K 5/10 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/542 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/58 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/645 (2013.01); A61K 2039/70 (2013.01); C12N 2720/12334 (2013.01); C12N 2770/16034 (2013.01);
Abstract

A substituted Norovirus capsid protein monomer, having only the P-domain, includes a foreign antigen inserted into one or more of three surface loops present on each P-domain monomer by molecular cloning. The antigen-P-domain monomer can assemble spontaneously into an octahedral, antigen-Norovirus P-particle, composed of 24 copies of the monomer. Each substituted P-domain monomer can contain one to three copies of the foreign antigen, for a total of 24-72 antigen copies on each antigen-P-particle. The antigen-P-particle is useful in methods for diagnosing, immunizing and treating individuals infected with a foreign virus and as a carrier for development of vaccines against many infectious and non-infectious diseases. The substituted monomer can be readily produced inand yeast, are highly stable and tolerate a wide range of physio-chemical conditions. The P-particle-VP8 chimeras may also serve as a dual vaccine, for example, against both rotavirus and norovirus.


Find Patent Forward Citations

Loading…